These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 34147030)

  • 21. Pheochromocytoma/Paraganglioma: Is This a Genetic Disorder?
    Fishbein L
    Curr Cardiol Rep; 2019 Jul; 21(9):104. PubMed ID: 31367972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective application of the pathologic tumor-node-metastasis classification system for pheochromocytoma and abdominal paraganglioma in a well characterized cohort with long-term follow-up.
    Stenman A; Zedenius J; Juhlin CC
    Surgery; 2019 Nov; 166(5):901-906. PubMed ID: 31239074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.
    Bausch B; Schiavi F; Ni Y; Welander J; Patocs A; Ngeow J; Wellner U; Malinoc A; Taschin E; Barbon G; Lanza V; Söderkvist P; Stenman A; Larsson C; Svahn F; Chen JL; Marquard J; Fraenkel M; Walter MA; Peczkowska M; Prejbisz A; Jarzab B; Hasse-Lazar K; Petersenn S; Moeller LC; Meyer A; Reisch N; Trupka A; Brase C; Galiano M; Preuss SF; Kwok P; Lendvai N; Berisha G; Makay Ö; Boedeker CC; Weryha G; Racz K; Januszewicz A; Walz MK; Gimm O; Opocher G; Eng C; Neumann HPH;
    JAMA Oncol; 2017 Sep; 3(9):1204-1212. PubMed ID: 28384794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy.
    Parasiliti-Caprino M; Lucatello B; Lopez C; Burrello J; Maletta F; Mistrangelo M; Migliore E; Tassone F; La Grotta A; Pia A; Reimondo G; Giordano R; Giraudo G; Piovesan A; Ciccone G; Deandreis D; Limone P; Orlandi F; Borretta G; Volante M; Mulatero P; Papotti M; Aimaretti G; Terzolo M; Morino M; Pasini B; Veglio F; Ghigo E; Arvat E; Maccario M
    Hypertens Res; 2020 Jun; 43(6):500-510. PubMed ID: 31586159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic pheochromocytoma and paraganglioma.
    Angelousi A; Kassi E; Zografos G; Kaltsas G
    Eur J Clin Invest; 2015 Sep; 45(9):986-97. PubMed ID: 26183460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and Management of Hereditary Phaeochromocytoma and Paraganglioma.
    Lalloo F
    Recent Results Cancer Res; 2016; 205():105-24. PubMed ID: 27075351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma.
    Buffet A; Ben Aim L; Leboulleux S; Drui D; Vezzosi D; Libé R; Ajzenberg C; Bernardeschi D; Cariou B; Chabolle F; Chabre O; Darrouzet V; Delemer B; Desailloud R; Goichot B; Esvant A; Offredo L; Herman P; Laboureau S; Lefebvre H; Pierre P; Raingeard I; Reznik Y; Sadoul JL; Hadoux J; Tabarin A; Tauveron I; Zenaty D; Favier J; Bertherat J; Baudin E; Amar L; Gimenez-Roqueplo AP;
    J Clin Endocrinol Metab; 2019 Apr; 104(4):1109-1118. PubMed ID: 30698717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pheochromocytoma and paraganglioma.
    Pacak K; Wimalawansa SJ
    Endocr Pract; 2015 Apr; 21(4):406-12. PubMed ID: 25716634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics, diagnosis, and management of medullary thyroid carcinoma and pheochromocytoma/paraganglioma.
    Moraitis AG; Martucci VL; Pacak K
    Endocr Pract; 2014 Feb; 20(2):176-87. PubMed ID: 24449662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastatic pheochromocytoma and paraganglioma: recent advances in prognosis and management.
    Hamidi O
    Curr Opin Endocrinol Diabetes Obes; 2019 Jun; 26(3):146-154. PubMed ID: 30893083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pheochromocytoma and paraganglioma in children and adolescents.
    Stachowicz-Stencel T; Pasikowska N; Synakiewicz A
    Acta Biochim Pol; 2023 Sep; 70(3):487-493. PubMed ID: 37717273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and epigenetic differences of benign and malignant pheochromocytomas and paragangliomas (PPGLs).
    Khatami F; Mohammadamoli M; Tavangar SM
    Endocr Regul; 2018 Jan; 52(1):41-54. PubMed ID: 29453919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma.
    Taïeb D; Pacak K
    Cell Tissue Res; 2018 May; 372(2):393-401. PubMed ID: 29450723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options.
    Eid M; Foukal J; Sochorová D; Tuček Š; Starý K; Kala Z; Mayer J; Němeček R; Trna J; Kunovský L
    Cancer Med; 2023 Jul; 12(13):13942-13957. PubMed ID: 37145019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
    Garcia-Carbonero R; Matute Teresa F; Mercader-Cidoncha E; Mitjavila-Casanovas M; Robledo M; Tena I; Alvarez-Escola C; Arístegui M; Bella-Cueto MR; Ferrer-Albiach C; Hanzu FA
    Clin Transl Oncol; 2021 Oct; 23(10):1995-2019. PubMed ID: 33959901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pheochromocytoma and paraganglioma: basics for the general practitioner].
    Loosli N; Köhler BB; Pechère-Bertschi A; Karenovics W; Triponex F
    Rev Med Suisse; 2014 Sep; 10(441):1650-2, 1654-5. PubMed ID: 25322623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis and management of metastatic pheochromocytoma and paraganglioma].
    Jochmanová I; Lazúrová I
    Vnitr Lek; 2017; 63(9):580-588. PubMed ID: 29120654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.
    Nölting S; Grossman AB
    Endocr Pathol; 2012 Mar; 23(1):21-33. PubMed ID: 22391976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment.
    Martucci VL; Pacak K
    Curr Probl Cancer; 2014; 38(1):7-41. PubMed ID: 24636754
    [No Abstract]   [Full Text] [Related]  

  • 40. Hereditary Neuroendocrine Tumors: Providing Comprehensive Care for Individuals Who Have a Germline Pathogenic Variant Associated With Paragangliomas and Pheochromocytomas.
    Mahon SM
    Clin J Oncol Nurs; 2021 Apr; 25(2):137-141. PubMed ID: 33739340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.